mRNA processing Flashcards

1
Q

General information about mRNA processing

A

Nucleus
preRNA processed to form mature mRNA
promotor start of 5’ end
information for mRNA is discontinuous in DNA
Exons joined in order they are in DNA to form a functional gene
introns are removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the splice donor site

A

where the splicosome binds at the beginning of an intron
motif that cell looks for
AGGU
5’ end

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the spliceosome

A

snRNP and pre- mRNA complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the addition of the polyA tail

A
polyadenylation 
added to 3' end 
one base at a time 
11-30 bases down from AAUAAA
prevent degredation in cytoplasm 
get shorter - regulate translation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain the addition of the cap

A

modified guanine nucleotide
Added to 5’ end - phosphodiester
hydrolysis terminal phosphate mRNA
reacts with a-phosphate of GTP - 5’-5’ phosphate linkage
Cap methylated N7 position purine ring - 7-methylguanylate cap
help bind to small subunit (40s) of the ribosome
prevent degradation in the cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

explain bacterial transcription

A

All coding information for 1 protein is in 1 block
once transcribed the mRNA is used straight away in the same place
Only 1 RNA pol
Sigma factors - bring RNA pol to different sections of genes
promotor is ‘pribnow box’ TATAAA
This is different to eukaryotes - target for AB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The other name for pre-RNA

A

Heterogenous nuclear RNA (hnRNA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sequence of events in RNA processing

A

introns start with GU and end with AG
uses small ribonuclear proteins - snRNPs
U1 bind AGGU (splice donor site)
U2, U4, U5 (splice acceptor CAG), U6 binding - complete spliceosome (protein and preRNA)
cleavage of splice donor sequence AG GU - phosphodiester bond broken
Tries to fold
A residue in intron - branchpoint
GU bind to A - phosphodiester 5’ phosphate G, 2’ OH A
Phosphodiester at end intron cleaved
lariat structure - recognised as waste and broken down
adjacent exons ligated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the splice acceptor site

A
bases end of intron
Pry15NCAG
CAG - highly conserved 
U5 bind 
3' end
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is a mutation

A

heritable change in sequence of gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

proportion of mutations in human disease in splice donor/acceptor

A

33%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is thalassemia

A

inherited disorder

imbalance in amount of globulin chains (a and B) in Hb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

complications as a result of thalassemia

A
severe anaemia - 12 months
extramedullary haematopoiesis
hepatomegaly/hepatospenomegaly - attempt to produce more RBC 
iron overload - excessive absorbtion of iron due to anaemia 
hepatic fibrosis and cirrhosis 
skin darkening 
cardiomyopathy 
endocrinopathies 
 skull attempt to make RBC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

distribution of thalassemia

A

more people on silk road - trade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the cause of B thalassemia

A

deficiency in B chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

benefit of thalassaemia

A

protection from malaria

17
Q

treatment of thalassaemia

A

blood transfusion

18
Q

mRNA splicing and DMD

A

Dystrophin gene mutation
deletion of at least 1 exon affect boys
muscle wastage

19
Q

how can DMD be mild

A

a lot of exons
mutation spliced around as it is repeated
alternative splicing

20
Q

Polio and RNA processing

A

interfere with recognition of CAP during translation

decapitate nerve cells